Nauman Shah, J&J global head for business development

J&J’s deal­mak­er: Plen­ty of ‘fire­pow­er,’ but most­ly fo­cused on tuck-in M&A

SAN DIEGO — The head of deal­mak­ing at John­son & John­son said that biotech val­u­a­tions have come back down to more rea­son­able lev­els that make it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.